Search
Close this search box.
Search
Subscriber Log In

More in Hope than Expectation: Biopharma in 2023

More-Hope-than-Expectation-Biopharma-2023-featured-image

Few people are expecting biopharma to stage a spectacular comeback in 2023 but what can we reasonably hope for – and when? I joined the world of biopharma in 2022 and it seems I didn’t pick a vintage year. M&A activity was weak, share prices plummeted and IPOs were all but non-existent. However, I have […]